Trump and Elon spent the week blaming each other for Ukraine’s Starlink slowdown while Russia kept bombing. Then they made up and Trump gave Elon a science medal. The media is furious at both of them either way. 🤡
Elon laid out a path to peace between Ukraine and Russia back in October 2022, and he was attacked for it by almost everyone
In November 2023, he explained to Lex Fridman why he had proposed peace: “a lot of people dying for basically almost no changes in land,” with an entire generation of young Ukrainians and Russians paying the price
Two and a half years after his original proposal, he warned that Ukraine should seek peace or suffer severe loss of life for no gains, and called continuing the war cruel and inhumane
Today the world is talking about the same kind of deal he proposed, only after hundreds of thousands more lives were thrown into a meat grinder for almost nothing
He was right then, and he is right now
Danielle from Iowa survived childhood leukemia, but chemotherapy left her with joint and nerve damage, and the usual painkillers caused internal bleeding. "It has truly saved my career, my sanity, and my quality of life."
Real stories. Real relief.
Story via https://t.co/TM22g2jjzb
Senators @ChuckGrassley@SenMikeLee@SenatorCollins, Secretary @SecKennedy, and Secretary @SecMullinDHS@HaddowMac
We share a responsibility to protect children, prevent dangerous products from reaching consumers, and ensure that federal policy follows the evidence. I am asking you to work with responsible manufacturers, independent researchers, clinicians, and adult consumers to pass meaningful federal legislation regulating natural kratom products.
Your October 7 letter raises legitimate concerns about potent synthetic and semisynthetic opioids sold under the kratom name. Those concerns deserve action. They also demand precision.
Traditional kratom leaf, its naturally occurring alkaloids, concentrated 7-OH products, and chemically modified compounds such as MGM-15, MGM-16, and mitragynine pseudoindoxyl are not interchangeable. Their composition, dose, pharmacology, and risks must be evaluated separately. FDA itself has distinguished its actions against concentrated and synthetic 7-OH products from natural kratom leaf products.
Natural does not automatically mean safe. Equally, a substance’s botanical origin does not make every chemically modified derivative scientifically equivalent to the original plant.
Under 21 U.S.C. § 811, ordinary permanent scheduling proceedings require scientific and medical evaluation and consideration of statutory factors, including abuse potential, pharmacology, dependence liability, and public-health risk. Aggregated reports involving “kratom,” mitragynine, and 7-OH cannot, by themselves, establish which product caused an outcome or justify treating every formulation identically.
Millions of Americans use kratom. Their experiences deserve a place in this discussion alongside adverse-event reports and clinical research.
Protecting children also requires accurate claims. Published national survey research has documented low—but nonzero—adolescent kratom use. That evidence does not establish a widespread epidemic of children abusing traditional kratom products. Exposure reports must distinguish accidental ingestion from intentional use, identify ages and actual ingredients, and account for other substances involved.
I support a federal bill that would:
• Establish a clear, enforceable pathway for natural kratom products that meet defined safety and manufacturing requirements.
• Require age 21+ sales, meaningful age verification, and prohibitions on marketing to children.
• Require verified ingredient identity, batch traceability, contaminant testing, accurate alkaloid labeling, and evidence-based serving limits.
• Require appropriate warnings, adverse-event reporting, inspections, and enforceable recall authority.
• Prohibit synthetic and semisynthetic opioid adulterants, added or artificially enhanced 7-OH, and deceptive substitution of new opioid compounds into products sold as kratom.
• Preserve legitimate scientific research while removing these unapproved opioid products from the consumer marketplace.
As a manufacturer, I am prepared to be held to enforceable standards and to help develop legislation that holds the entire industry accountable.
Let’s bring the relevant scientists, regulators, manufacturers, and consumers to the same table. We can protect children, remove dangerous adulterated products, and preserve a responsible pathway for adult access to natural kratom.
I welcome the opportunity to meet with your offices and help turn those shared objectives into federal law.
#Kratom #NaturalKratom #KratomRegulation #KratomConsumerProtection #ConsumerSafety #ProtectChildren #PublicHealth #ScienceBasedPolicy #EvidenceBasedPolicy #FederalLegislation #BipartisanSolutions #ConsumerProtection #ProductSafety #ManufacturingStandards #GMP #Accountability #Transparency #BotanicalResearch #HarmReduction #7OH #SyntheticOpioids #FDA #HHS #DEA #Congress #USSenate
There’s been a couple high profile American 7-OH related deaths in the news recently. One was a NBA player, the other a hip hop producer. Autopsies showed both had alcohol, cocaine, heroine and prescription pills in their system but of course it’s the kratom that’s the problem 🤦🏻♂️
LEFT: Traditional kratom leaf.
RIGHT: “PERKS” 7-OH tablets labeled “EXTREMELY POTENT.”
Stop pretending these are the same damn thing. Blue razz tablets don’t grow on trees.
As the Ole Miss tragedy draws attention, demand verified facts and accurate product identification. Families deserve answers. The public deserves the truth—not every product lumped under “kratom.”
To be fair on Ole Miss it was MGM15 found, still waiting on complete toxicology.
Protect traditional kratom. Stop hiding behind its name.
#Kratom #7OH #OleMiss #UniversityOfMississippi #OxfordMS #Mississippi #ConsumerSafety #ConsumerProtection #ProductTransparency #ProtectKratom #KratomAwareness #PublicHealth
Thanks @JeniferPMartin1
FYI @JeromeAdamsMD
A panel of Pennsylvania House members advanced a bill Tuesday that would allow the sale of some kratom products to continue in the state, while banning others and creating stricter regulations for sellers.
Under the proposed law, retailers who register with the state would be allowed to sell natural leaf kratom products to people 21 and over. But those products would have to meet strict packaging requirements and be subject to the tobacco tax.
Packages would have to include the manufacturer’s name and address, a warning that the products have not been evaluated by the U.S. Food and Drug Administration (FDA) and not contain any medical claims. They would also have to be child resistant and not designed to appeal to minors.
The bill would also ban the sale of so-called synthetic or adulterated kratom products, including those that contain more than .5% alkaloid composition of 7-hydroxymitraynine or 7-OH, a potent intoxicating compound found in only trace amounts in the kratom leaf. Violators would be subject to criminal penalties, though those would target sellers and not individual users.
https://t.co/tvT4NSxbmC
Standing with Oxford Police on the most recent statement on the Ole Miss Investigation:
Differentiating Botanicals from Illicit Synthetics: The Global Kratom Coalition strongly supports the Oxford Police Department and Lafayette County Metro Narcotics in their most recent accurate assessment of the recent tragedies at Ole Miss.
Local investigators have rightly emphasized the critical line between traditional botanical kratom leaf and illegal concentrated synthetic opioid products. The evidence collected in Oxford centered on "Smax" pressed tablets containing concentrated synthetic alkaloids —not unadulterated botanical leaf.
The Path Forward: Acknowledge the Evidence and await finalized toxicology rather than further speculation.
Follow the Federal Lead: Align state regulatory frameworks with the DEA's emergency scheduling of novel synthetics, including mitragynine pseudoindoxyl, MGM-15, and the pending scheduling of concentrated synthetic 7-OH.
Target the Harm: Give law enforcement the tools needed to enforce the Federal and State regulations that currently exist to remove dangerous synthetics from the market.
By supporting law enforcement's call to differentiate between plants and pills, lawmakers can close loopholes on dangerous synthetic derivatives while protecting responsible adult access to the natural leaf.
Read the full analysis: https://t.co/M6PQeMhjFG
Centuries of traditional kratom use matter. But fresh leaf, filtered tea, dried powder, extracts and chemically altered derivatives are not necessarily the same exposure. Traditional use is evidence. It just isn’t a safety study for everything we in the western market now call “kratom.”
Good policy starts by recognizing those differences. You cannot honestly assess risk if you keep pretending everything with a kratom connection is the same product.
https://t.co/9NVZkefxyZ